MGMT and central nervous system cancer: Figures 2A–H shows significant differences in ADC histogram profile parameters between WHO grade I and II astrocytomas, Figures 2I,J illustrates differences of ADC Entropy and ADCmin considering IDH-1 mutation status and MGMT promotor methylation status of the investigated gliomas.